Cite
Multinu F, Garzon S, Weaver AL, et al. Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes. Int J Gynecol Cancer. 2021;31(4):537-544doi: 10.1136/ijgc-2020-002094.
Multinu, F., Garzon, S., Weaver, A. L., McGree, M. E., Sartori, E., Landoni, F., Zola, P., Dinoi, G., Aletti, G., Block, M. S., Gadducci, A., & Mariani, A. (2021). Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 31(4), 537-544. https://doi.org/10.1136/ijgc-2020-002094
Multinu, Francesco, et al. "Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 31,4 (2021): 537-544. doi: https://doi.org/10.1136/ijgc-2020-002094
Multinu F, Garzon S, Weaver AL, McGree ME, Sartori E, Landoni F, Zola P, Dinoi G, Aletti G, Block MS, Gadducci A, Mariani A. Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes. Int J Gynecol Cancer. 2021 Apr;31(4):537-544. doi: 10.1136/ijgc-2020-002094. Epub 2021 Feb 19. PMID: 33608453; PMCID: PMC8109194.
Copy
Download .nbib